Israel Englander Maxcyte, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Maxcyte, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,378,329 shares of MXCT stock, worth $3.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,378,329

Previous 2,740,871 49.71%

Holding current value

$3.13 Million

Previous $11.4 Million 67.01%

% of portfolio

0.0%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.73 - $5.1 $3.72 Million - $6.95 Million	-1,362,542 Reduced 49.71%	1,378,329 $3.76 Million
Q4 2024 Feb 14, 2025	SELL	$3.23 - $4.43 $4.69 Million - $6.43 Million	-1,451,994 Reduced 34.63%	2,740,871 $11.4 Million
Q3 2024 Nov 14, 2024	SELL	$3.68 - $5.06 $3.63 Million - $4.98 Million	-985,088 Reduced 19.02%	4,192,865 $16.3 Million
Q2 2024 Aug 14, 2024	SELL	$3.63 - $5.0 $3.6 Million - $4.97 Million	-993,093 Reduced 16.09%	5,177,953 $20.3 Million
Q1 2024 May 15, 2024	BUY	$3.94 - $5.38 $4.57 Million - $6.23 Million	1,158,763 Added 23.12%	6,171,046 $25.9 Million
Q4 2023 Feb 14, 2024	BUY	$2.6 - $5.24 $8 Million - $16.1 Million	3,075,291 Added 158.77%	5,012,283 $23.6 Million
Q2 2023 Aug 14, 2023	SELL	$3.69 - $5.35 $3.36 Million - $4.87 Million	-910,161 Reduced 31.97%	1,936,992 $8.89 Million
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $3.82 Million - $5.59 Million	948,640 Added 49.97%	2,847,153 $14.1 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $7.4 $2.33 Million - $3.51 Million	474,178 Added 33.29%	1,898,513 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$4.52 - $6.51 $4.21 Million - $6.06 Million	-930,751 Reduced 39.52%	1,424,335 $9.26 Million

Others Institutions Holding MXCT

# of Institutions

119

Shares Held

73.2M

Call Options Held

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $231M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account